New national evidence review released

NEWS-STORY  |  22 DECEMBER, 2017

The Commonwealth Therapeutic Goods Administration (TGA) today released a summary for patients about the national review of the scientific evidence for the use of cannabis medicines in five areas: palliative care, nausea and vomiting, epilepsy, multiple sclerosis and pain. 

More information is available on the TGA website and can be found here.

Related articles

Could a cannabis pill reduce chemotherapy-induced nausea and vomiting? Here’s how we find out

5 December 2016

Despite dozens of trials internationally, the evidence on medical cannabis is unconvincing. 

New national evidence review released

22 December, 2017

The Commonwealth Therapeutic Goods Administration (TGA) today released a summary for patients about the national review of the scientific evidence for the use of cannabis medicines in five areas: palliative care, nausea and vomiting, epilepsy, multiple sclerosis and pain.

Palliative care doctor: Medicinal cannabis is NOT a magic cure

5 December 2016

To the desperate parent I would say: “I am not certain that cannabidiol will help your child, in fact, it is most likely that it won’t have a big benefit.”